MEDISCA Brings LP3 Network’s World-Renowned Hormone Replacement Therapy Event to the United Kingdom

LONDON–(BUSINESS WIRE)–After many successful events across the United States, Canada, Brazil,
Australia, New Zealand, Malaysia, and the Philippines, Medisca UK is
excited to bring LP3 Network’s globally recognised educational program, Functional
Hormone Replacement Therapy (HRT), to the United Kingdom on October
4-6, 2019!

“One of the first things we noticed when opening Medisca UK is the high
demand for education on functional HRT, a rapidly expanding treatment
area in Europe,” said Andrew Rowe, Medisca UK General Manager. “Through
partnership with LP3 Network, European physicians, pharmacists, and
other functional medicine providers will now have access to the
international gold standard for Continuing Professional Development in
integrative HRT.”

Paired with a 9-hour home study, this 3-day interactive seminar affords
practitioners 33 hours of practical and outcome-focused education
designed to elevate performance of professional practice. Through case
study assessments, this program delves into the physiology of hormonal
signalling, evaluates the safety and efficacy of HRT, examines
considerations for hormone testing, and applies an integrative approach
that addresses the underlying cause of hormonal conditions.

“Our primary objective at LP3 Network is to bring you the elite in the
industry,” said Maurizio De Stefano, LP3 Network General Manager. “With
Dr Tara Scott, certified menopause practitioner, and Dr Ken Speidel,
pharmacotherapeutic specialist in endocrinology, as the facilitators and
subject-matter experts, participants will gain unparalleled education in
the niche field of HRT.”

LP3 Network has helped over 12,000 professionals optimise patient
therapeutic outcomes through personalised alternative approaches in
medicine. With a global reach to more than 50 countries, LP3 Network is
excited to partner with Medisca UK to further extend its wealth of
expertise to the United Kingdom.

Learn more: https://education.lp3network.com/live-training/HRT-UK.

About MEDISCA®

Proudly celebrating 30 years of industry excellence, Medisca is the
leader in providing high-quality products to the pharmaceutical
compounding industry and allied health care professionals worldwide.
Together with its global partners, LP3 Network, provider of continuing
education, and Medisca Network, provider of advanced formulation
support, Medisca and its affiliates offer turnkey solutions for
prescribers and pharmacists engaged in personalised medicine. Our
perennial pursuit to address growing demands in this evolving field is
fueled by our dedication to our customers. Medisca is established in
Canada, the United States, the United Kingdom, and Australia.

Contacts

Andrew Rowe
General Manager Europe
arowe@medisca.com
+44
(0)20 3966 1991